Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 391-400 of 410 for multiple

Edit search filters
  1. A Study to Evaluate the Safety, Tolerability and Metabolism of BIIB105 in Subjects with Amyotrophic Lateral Sclerosis

    Jacksonville, FL

  2. A Study of Demyelinating Lesions as a Cause of Progressive Motor Deterioration

    Rochester, MN

  3. A Study to Collect and Correlate the Data from Multiple Risk Assessments for Heart Toxicity in Patients Receiving Chemotherapy for Breast Cancer

    Rochester, MN

  4. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    Albert Lea, MN, Eau Claire, WI, La Crosse, WI, Mankato, MN

  5. A New Hand-held Electronic Device Tool for Self-assessment of Neurological Disability: Mayo Clinic Electronic Emoji Based Neurological Impairment Status (MEBNIS)

    Rochester, MN

  6. Stress Echocardiography in Mixed and Multi Valvular Heart Disease

    Rochester, MN

  7. A Study of the Natural History of Monoclonal Gammopathy of Undetermined Significance (MGUS) Over Time

    Rochester, MN

  8. Collection of Pharmacogenomics (PGx) Results and Clinical Data of Aging Poly-Pharm Patients of the Individualized Medicine Clinic to Assess Current and Future Therapeutic Relevance

    Rochester, MN

  9. Patient Experience with Treatment and Self-care Clinical Tool: Patient and Healthcare Provider Discussion Groups

    Rochester, MN

  10. Developing Criteria for Treatment of Neurofibromatosis Type 1 Associated Optic Pathway Glioma

    Rochester, MN

.

Mayo Clinic Footer